Dissecting the molecular mechanisms of TCR zeta chain downregulation and T cell signaling abnormalities in human systemic lupus erythematosus
- PMID: 15204087
- DOI: 10.1080/08830180490452602
Dissecting the molecular mechanisms of TCR zeta chain downregulation and T cell signaling abnormalities in human systemic lupus erythematosus
Abstract
Abnormal expression of key signaling molecules and defective function of T lymphocytes play a significant role in the pathogenesis of systemic lupus erythematosus (SLE). Probing on altered expression of genes that may predispose to SLE revealed that the expression of TCR zeta chain is defective in the majority of SLE patients. Current research has been directed towards understanding the molecular basis of TCR zeta chain deficiency and dissecting the T cell signalling abnormalities in SLE T cells. Latest developments suggest that interplay of abnormal transcriptional factor expression, aberrant mRNA processing/editing, unbiquitination, proteolysis, and the effects of oxidative stress as well as changes in chromatin structure invariably contribute to TCR zeta chain deficiency in SLE T cells. On the other hand, multiple factors, including altered receptor structure, modulation of membrane clustering, lipid-raft distribution of signaling molecules, and defective signal silencing mechanisms, play a key role in delivering the increased TCR/CD3-mediated intracellular calcium response in SLE T cells.
Similar articles
-
TCR zeta-chain abnormalities in human systemic lupus erythematosus.Methods Mol Med. 2004;102:49-72. doi: 10.1385/1-59259-805-6:049. Methods Mol Med. 2004. PMID: 15286380
-
Abnormal expression of various molecular forms and distribution of T cell receptor zeta chain in patients with systemic lupus erythematosus.Arthritis Rheum. 2002 Jan;46(1):163-74. doi: 10.1002/1529-0131(200201)46:1<163::AID-ART10065>3.0.CO;2-J. Arthritis Rheum. 2002. PMID: 11817588
-
Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.Arthritis Rheum. 2003 Jul;48(7):1948-55. doi: 10.1002/art.11072. Arthritis Rheum. 2003. PMID: 12847689
-
Altered expression of the T cell receptor-CD3 complex in systemic lupus erythematosus.Int Rev Immunol. 2004 May-Aug;23(3-4):273-91. doi: 10.1080/08830180490452594. Int Rev Immunol. 2004. PMID: 15204089 Review.
-
Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients.Autoimmun Rev. 2006 Feb;5(2):143-4. doi: 10.1016/j.autrev.2005.09.004. Epub 2005 Sep 19. Autoimmun Rev. 2006. PMID: 16431347 Review.
Cited by
-
Assessing Autophagy in Mouse Models and Patients with Systemic Autoimmune Diseases.Cells. 2017 Jun 28;6(3):16. doi: 10.3390/cells6030016. Cells. 2017. PMID: 28657591 Free PMC article. Review.
-
Genetic polymorphisms of CYP2D6 oxidation in patients with systemic lupus erythematosus.Arch Med Sci. 2011 Oct;7(5):864-9. doi: 10.5114/aoms.2011.25563. Epub 2011 Nov 8. Arch Med Sci. 2011. PMID: 22291833 Free PMC article.
-
Autophagy in autoimmune disease.J Mol Med (Berl). 2015 Jul;93(7):707-17. doi: 10.1007/s00109-015-1297-8. Epub 2015 Jun 10. J Mol Med (Berl). 2015. PMID: 26054920 Free PMC article. Review.
-
Macroautophagy is deregulated in murine and human lupus T lymphocytes.Autophagy. 2012 Jul 1;8(7):1113-23. doi: 10.4161/auto.20275. Epub 2012 Apr 23. Autophagy. 2012. PMID: 22522825 Free PMC article.
-
Downregulation of CD3ζ in NK Cells from Systemic Lupus Erythematosus Patients Confers a Proinflammatory Phenotype.J Immunol. 2018 May 1;200(9):3077-3086. doi: 10.4049/jimmunol.1700588. Epub 2018 Mar 30. J Immunol. 2018. PMID: 29602774 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
